REQUEST A DEMO
Total
USD $0.00
Search more companies

Clinical Research Fund OU (Estonia)

Main Activities: All Other Professional, Scientific, and Technical Services
Full name: Clinical Research Fund OU Profile Updated: December 22, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Clinical Research Fund OU is a company in Estonia, with a head office in Tallinn. It operates in the All Other Professional, Scientific, and Technical Services industry. It was established on December 04, 2020. From the latest financial highlights, Clinical Research Fund OU reported a net sales revenue increase of 246.08% in 2024. Over the same period, its total assets grew by 326.57%. The enterprise’s net profit margin increased by 12.18% in 2024.

Headquarters
Sakala tn 7-2 Kesklinna linnaosa
Tallinn; Harju county; Postal Code: 10141

Contact Details: Purchase the Clinical Research Fund OU report to view the information.

Basic Information
Registered Capital:
Purchase the Clinical Research Fund OU report to view the information.
Financial Auditors:
Purchase the Clinical Research Fund OU report to view the information.
Incorporation Date:
December 04, 2020
Key Executives
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Clinical Research Fund OU report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
246.08%
Total operating revenue
246.08%
Operating Profit/Loss (EBIT)
343.48%
EBITDA
343.48%
Net Profit/Loss for the Period
307.18%
Total Assets
326.57%
Total Equity
304.34%
Operating Profit Margin (ROS)
19.44%
Net Profit Margin
12.18%
Return on Equity (ROE)
0.55%
Cash Ratio
-179.54%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?